Atea Pharmaceuticals receives director nominations from two stockholders for 2025 Annual Meeting

Atea Pharmaceuticals, Inc.

Bradley L. Radoff nominates Howard H. Berman, James P. Flynn, and Michael Torok.
Driver Opportunity Partners III LP nominates J. Abbott R. Cooper for election.
Nominating Committee will evaluate candidates; formal recommendation in proxy statement.
No shareholder action required now; 2025 Annual Meeting date not yet scheduled.
Evercore and Latham & Watkins retained as financial and legal advisors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.